Manfred Danilovitš

2.8k total citations
13 papers, 908 citations indexed

About

Manfred Danilovitš is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Manfred Danilovitš has authored 13 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Manfred Danilovitš's work include Tuberculosis Research and Epidemiology (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Pneumonia and Respiratory Infections (5 papers). Manfred Danilovitš is often cited by papers focused on Tuberculosis Research and Epidemiology (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Pneumonia and Respiratory Infections (5 papers). Manfred Danilovitš collaborates with scholars based in Estonia, Russia and United Kingdom. Manfred Danilovitš's co-authors include Klavdia Levina, Vaira Leimane, Charles D. Wells, Lea Pehme, Tiina Kummik, Andra Cīrule, Lawrence Geiter, Davide Manissero, Ģirts Šķenders and Heinart Sillastu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Manfred Danilovitš

13 papers receiving 871 citations

Peers

Countries citing papers authored by Manfred Danilovitš

Since Specialization

Citations

This map shows the geographic impact of Manfred Danilovitš's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Danilovitš with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Danilovitš more than expected).

Fields of papers citing papers by Manfred Danilovitš

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Danilovitš. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Danilovitš. The network helps show where Manfred Danilovitš may publish in the future.

Co-authorship network of co-authors of Manfred Danilovitš

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Danilovitš. A scholar is included among the top collaborators of Manfred Danilovitš based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Danilovitš. Manfred Danilovitš is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Real-life use of delamanid: results from the European post-authorisation safety study 2024 ·SHILAP Revista de lepidopterología ·Nicolas Schönfeld, (unknown), (unknown), Manfred Danilovitš, Skaidrius Miliauskas, Florence Ader, Onn Min Kon, Christoph Lange, Alexandre Duvignaud, Marion Heiß-Neumann, Norbert Hittel, (unknown), (unknown), Alexandra Martin, (unknown), (unknown), (unknown)	1
2	Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines 2021 ·The International Journal of Tuberculosis and Lung Disease ·Thijs Feuth, (unknown), Sylvia S. Grierson, Manfred Danilovitš, Piret Viiklepp, (unknown), (unknown), Lea Pehme, Tuula Vasankari	3
3	Safety and immunogenicity of the M72/AS01 E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study 2016 ·Tuberculosis ·Paul Gillard, Pan‐Chyr Yang, Manfred Danilovitš, Wei‐Juin Su, Shih-Lung Cheng, Lea Pehme, Anne Bollaerts, Erik Jongert, Philippe Moris, Opokua Ofori‐Anyinam, Marie‐Ange Demoitié, Marcela Castro	55
4	Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference? 2016 ·Thorax ·Yanina Balabanova, Olga Ignatyeva, Lena Fiebig, Vija Riekstiņa, Manfred Danilovitš, (unknown), Edita Davidavičienė, (unknown), (unknown), Vladyslav Nikolayevskyy, Francis Drobniewski	23
5	Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis 2015 ·European Respiratory Journal ·Alexander S. Pym, Andreas H. Diacon, Shenjie Tang, Francesca Conradie, Manfred Danilovitš, Charoen Chuchottaworn, I. А. Vаsilyevа, Koen Andries, Nyasha Bakare, Tine De Marez, (unknown), Nacer Lounis, Paul Meyvisch, Ben Van Baelen, Rolf P. G. van Heeswijk, Brian Dannemann	226
6	Resistance profile and risk factors of drug resistant tuberculosis in the Baltic countries 2015 ·Tuberculosis ·Olga Ignatyeva, Yanina Balabanova, Vladyslav Nikolayevskyy, (unknown), (unknown), Edita Davidavičienė, Vija Riekstiņa, (unknown), Manfred Danilovitš, (unknown), Francis Drobniewski	19
7	Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional Study 2015 ·PLoS ONE ·Helen R. Stagg, James Brown, Elmira Ibraim, Vija Riekstiņa, Piret Viiklepp, Andra Cīrule, (unknown), Manfred Danilovitš, Gunta Dravniece, Charlotte Jackson, Peter J White	11
8	Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis 2015 ·Bulletin of the World Health Organization ·Thelma E. Tupasi, Rajesh Gupta, Manfred Danilovitš, Andra Cīrule, (unknown), Heping Xiao, José Luis Cabrera, (unknown), Mengqiu Gao, Mohamed Awad, (unknown), Lawrence Geiter, Charles D. Wells	5
9	A four-year nationwide molecular epidemiological study in Estonia: risk factors for tuberculosis transmission 2014 ·Public Health Action ·Kadri Toit, Alan Altraja, (unknown), Piret Viiklepp, Kristin Kremer, Tiina Kummik, Manfred Danilovitš, Rafaël Van den Bergh, Anthony Harries, Philip Supply	14
10	Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia 2012 ·European Respiratory Journal ·Katherine Floyd, Raymond Hutubessy, Kai Kliiman, Rosella Centis, (unknown), (unknown), Manfred Danilovitš, (unknown), Salmaan Keshavjee, Giovanni Battista Migliori	31
11	Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis 2012 ·European Respiratory Journal ·(unknown), Manfred Danilovitš, Lea Pehme, (unknown), Ģirts Šķenders, Tiina Kummik, Andra Cīrule, Vaira Leimane, (unknown), Klavdia Levina, Lawrence Geiter, Davide Manissero, Charles D. Wells	233
12	Multidrug-resistant Tuberculosis Management in Resource-limited Settings 2006 ·Emerging infectious diseases ·(unknown), (unknown), Michael Rich, Rajesh Gupta, Jaime Bayona, Kai Blöndal, José A. Caminero, J. Peter Cegielski, Manfred Danilovitš, Marcos Espinal, Vahur Hollo, Ernesto Jaramillo, Vaira Leimane, Carole D. Mitnick, Joia S. Mukherjee, Paul Nunn, Alexander Pasechnikov, Thelma E. Tupasi, Charles D. Wells, Mario Raviǵlione	134
13	Spread of Drug-Resistant Pulmonary Tuberculosis in Estonia 2001 ·Journal of Clinical Microbiology ·Annika Krüüner, Sven Hoffner, Heinart Sillastu, Manfred Danilovitš, Klavdia Levina, Stefan B. Svenson, Solomon Ghebremichael, Tuija Koivula, Gunilla Källenius	153

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact